Harm Reduction Journal

Scope & Guideline

Innovative strategies for impactful public health solutions.

Introduction

Welcome to your portal for understanding Harm Reduction Journal, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationHARM REDUCT J / Harm Reduct. J.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The Harm Reduction Journal is dedicated to advancing the understanding and implementation of harm reduction strategies in public health, particularly in the context of substance use. Its primary focus is on evidence-based practices that minimize the negative health, social, and legal impacts associated with drug use. The journal serves as a platform for interdisciplinary research that encompasses a variety of methodologies and perspectives.
  1. Substance Use and Public Health:
    Research focused on the public health implications of substance use, including opioid and alcohol-related harms, and strategies to mitigate these risks.
  2. Innovative Harm Reduction Strategies:
    Exploration of novel harm reduction practices, such as drug checking services, supervised consumption sites, and peer-led interventions.
  3. Community Engagement and Social Justice:
    Studies that highlight the importance of community involvement and the social determinants of health in shaping effective harm reduction policies and practices.
  4. Policy Analysis and Advocacy:
    Critical assessments of drug policies and their impact on harm reduction efforts, emphasizing the need for policy reform to support evidence-based practices.
  5. Mental Health and Substance Use:
    Investigations into the intersection of mental health issues and substance use, including the experiences of individuals who use drugs and the support systems available to them.
The Harm Reduction Journal has seen a dynamic evolution in its research focus, with emerging themes reflecting current public health challenges and innovative approaches to harm reduction. These trends are indicative of a responsive and adaptive research community.
  1. Impact of COVID-19 on Harm Reduction:
    Increasing research examining how the COVID-19 pandemic has affected harm reduction services, highlighting adaptations in service delivery and the unique challenges faced by people who use drugs.
  2. Integration of Technology in Harm Reduction:
    Emerging studies exploring the use of technology, such as telehealth and mobile apps, to enhance harm reduction services and improve access for marginalized populations.
  3. Focus on Stigma and Social Determinants:
    Growing attention to the role of stigma in substance use and its impact on health outcomes, alongside the exploration of social determinants that affect access to harm reduction services.
  4. Poly-Substance Use and Complex Interventions:
    A trend towards examining poly-substance use patterns and the need for complex, multifaceted interventions that address the realities of concurrent substance use.
  5. Community-Led Initiatives:
    Increased emphasis on community-led harm reduction initiatives, showcasing the effectiveness of peer support and local engagement in addressing substance use issues.

Declining or Waning

While the journal continues to thrive in several core areas, certain themes have seen a decline in frequency or prominence in recent publications. This shift may reflect changes in the landscape of harm reduction or a reallocation of research priorities.
  1. Traditional Drug Policy Critiques:
    There has been a noticeable decrease in papers solely focused on critiquing traditional drug policies, as the field increasingly emphasizes practical harm reduction strategies over theoretical debates.
  2. General Substance Use Trends Without Context:
    Research that discusses broad trends in substance use without linking them to specific harm reduction interventions or community impacts appears less frequently, suggesting a shift towards more targeted studies.
  3. Alcohol Harm Reduction Alone:
    The focus on alcohol-related harm reduction strategies has waned, with more attention now being directed towards the complexities of poly-substance use and the interplay between different substances.
  4. Psychosocial Studies Without Actionable Insights:
    Papers that explore the psychosocial aspects of drug use without providing actionable insights or interventions are becoming less common, as the field moves towards practical applications.

Similar Journals

Substance Abuse-Research and Treatment

Fostering interdisciplinary dialogue for better mental health outcomes.
Publisher: SAGE PUBLICATIONS LTDISSN: 1178-2218Frequency:

Substance Abuse: Research and Treatment is a premier open-access journal published by SAGE Publications Ltd, focusing on the multifaceted aspects of substance use and its impact on mental health. Since its establishment in 2008, this journal has been dedicated to disseminating innovative research findings, case studies, and reviews that enhance understanding and treatment of substance-related disorders. With an impact factor that reflects its standing in the field, currently ranked in the Q2 category of Psychiatry and Mental Health, Substance Abuse: Research and Treatment strives to foster interdisciplinary dialogue among researchers, practitioners, and students. By making its content freely accessible, the journal encourages widespread engagement and application of evidence-based practices to mitigate substance abuse issues. The journal’s diverse global perspectives make it a vital resource for anyone invested in advancing knowledge and improving treatment outcomes in this critical area of public health.

INTERNATIONAL JOURNAL OF DRUG POLICY

Advancing Global Perspectives on Drug Policy
Publisher: ELSEVIERISSN: 0955-3959Frequency: 12 issues/year

International Journal of Drug Policy, published by Elsevier, stands as a crucial scholarly platform dedicated to advancing the field of drug policy research. With an impactful focus on health policy and medicine, this journal holds a prestigious Q1 ranking in both Health Policy and Medicine (miscellaneous) categories as of 2023, reflecting its high-quality contributions to the discourse surrounding drug use, regulation, and public health. Spanning publication from 1998 to 2024, the journal's rich archive of research serves as an essential resource for researchers, professionals, and students alike. While the journal is not open access, it provides invaluable insights and significant findings that drive policy-making decisions and foster evidence-based practices in drug management and health interventions. With a Scopus rank of #28 out of 310 in Health Policy and #55 out of 398 in Medicine (miscellaneous), the International Journal of Drug Policy is indispensable for those committed to exploring and understanding the complexities of drug-related issues on a global scale.

Canadian Journal of Addiction

Bridging the gap between theory and practice in addiction studies.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2368-4720Frequency: 4 issues/year

Canadian Journal of Addiction is a leading platform dedicated to advancing the understanding of addiction and its multifaceted impacts on individuals and society. Published by LIPPINCOTT WILLIAMS & WILKINS, this journal aims to foster rigorous research and discussion in the field of addiction studies, contributing significantly to the intersection of psychiatry and mental health. With its ISSN 2368-4720 and E-ISSN 2368-4739, the journal is indexed in Scopus and has been categorized in the Q3 quartile for 2023, reflecting its emerging influence amongst peers. The Canadian Journal of Addiction facilitates a vital exchange of ideas and findings, crucial for researchers, practitioners, and students alike, addressing pressing issues related to addiction through innovative studies and insightful reviews. Subscribers and readers benefit from the latest findings as they navigate through the dynamic landscape of addiction research, enriching both academic knowledge and practical applications.

Drugs Habits and Social Policy

Transforming Understanding of Drug Habits through Scholarship
Publisher: EMERALD GROUP PUBLISHING LTDISSN: 2752-6739Frequency: 4 issues/year

Drugs Habits and Social Policy is an esteemed academic journal published by Emerald Group Publishing Ltd that focuses on the intersection of drug habits and the evolving landscape of social policy. With an ISSN of 2752-6739 and E-ISSN of 2752-6747, this journal contributes significantly to the fields of Clinical Psychology, Health Policy, and Public Health, and is ranked in the Q3 category across multiple disciplines in the 2023 categorizations. Featuring research that spans from 2022 to 2024, the journal provides a platform for critical insights and evidence-based discussions that are essential for understanding the social implications of drug use. Despite its current quartile ranking, the journal aims to elevate discourse among researchers, professionals, and students alike, reinforcing its commitment to impactful scholarship that can inform policy and practice. The journal is based in the United Kingdom, with its operations housed at Floor 5, Northspring 21-23 Wellington Street, Leeds, W YORKSHIRE LS1 4DL, ENGLAND. As a pivotal resource in its field, Drugs Habits and Social Policy invites contributions that can shape the future of health policy and improve societal outcomes.

JOURNAL OF PSYCHOACTIVE DRUGS

Advancing Knowledge on Drug Impact and Behavior
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 0279-1072Frequency: 4 issues/year

JOURNAL OF PSYCHOACTIVE DRUGS, published by Routledge Journals, Taylor & Francis Ltd, stands as a leading resource in the fields of psychology and medicine, focusing on the intersection of psychoactive substances and their impact on human behavior. With an ISSN of 0279-1072 and E-ISSN 2159-9777, this esteemed journal has been a pivotal platform for rigorous research since its inception in 1967, contributing to the understanding of drug use, its societal implications, and therapeutic potentials. It currently holds a Q2 ranking in both the miscellaneous categories of Medicine and Psychology for 2023, reflecting its significant standing within academic circles. Moreover, its Scopus rankings place it at the 49th percentile in General Psychology and 101st in Medicine, underscoring its relevance in contemporary research. Although it is not available via Open Access, the journal maintains a commitment to advancing knowledge through its annual publications until 2024. JOURNAL OF PSYCHOACTIVE DRUGS is essential for researchers, professionals, and students seeking to explore the complexities of psychoactive substances and their effects in various contexts.

Journal of Substance Use & Addiction Treatment

Innovating solutions for addiction recovery.
Publisher: ELSEVIER SCIENCE INCISSN: 2949-8767Frequency: 12 issues/year

Journal of Substance Use & Addiction Treatment is a premier scholarly publication dedicated to advancing the understanding and treatment of substance use disorders and addictive behaviors. Published by Elsevier Science Inc, this journal serves as a vital platform for researchers, clinicians, and students in the fields of psychology, psychiatry, public health, and addiction studies. With its commitment to Open Access, the journal facilitates wide dissemination of cutting-edge research, enabling practitioners and policymakers to access critical findings that inform treatment approaches and public health strategies. As an essential resource in addiction treatment and research, the Journal of Substance Use & Addiction Treatment aims to foster interdisciplinary collaboration and innovation, ultimately improving outcomes for individuals affected by addiction.

SUBSTANCE USE & MISUSE

Unraveling the intricacies of substance use to inform policy and practice.
Publisher: TAYLOR & FRANCIS INCISSN: 1082-6084Frequency: 14 issues/year

SUBSTANCE USE & MISUSE, published by Taylor & Francis Inc, is an esteemed academic journal dedicated to the multifaceted study of substance use and its implications on health and society. With a notable impact factor and categorized in the Q2 quartile across multiple fields—including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, as well as Public Health—this journal serves as an essential platform for researchers, professionals, and students alike. Spanning from 1966 to 2024, it provides a rich archive of peer-reviewed articles that explore current trends, innovative research, and evidence-based practices in the management and understanding of substance use. The journal offers various access options, catering to the diverse needs of its audience and affirming its commitment to fostering scholarly discourse in the United Kingdom and beyond. By engaging with this journal, readers can enhance their understanding of the complexities surrounding substance use, making it a crucial resource for advancing knowledge and informing policy in this critical area of public health.

JOURNAL OF ADDICTIVE DISEASES

Exploring the Frontiers of Addiction Science
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1055-0887Frequency: 4 issues/year

JOURNAL OF ADDICTIVE DISEASES, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, serves as a pivotal platform for researchers, clinicians, and students in the realms of clinical psychology, psychiatry, and addiction studies. With a distinguished history dating back to its inception in 1991, this journal spans critical research developments with its current scope covering converged years from 2018 to 2024, ensuring a robust repository of knowledge. Notably, it holds a respectable impact factor and is categorized in Q2 quartiles across several disciplines including Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health for 2023, reflecting its impactful contributions to the scientific community. Despite the journal not currently offering Open Access, it remains highly ranked, occupying positions in the top percentiles of Scopus rankings. This journal emphasizes the importance of disseminating high-quality research focused on addictive behaviors and diseases, thereby addressing vital clinical and public health challenges.

DRUG AND ALCOHOL DEPENDENCE

Advancing knowledge on substance use disorders.
Publisher: ELSEVIER IRELAND LTDISSN: 0376-8716Frequency: 12 issues/year

Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.

Substance Abuse

Fostering global conversations on mental health and addiction.
Publisher: SAGE PUBLICATIONS INCISSN: 0889-7077Frequency: 4 issues/year

Substance Abuse is a premier scholarly journal published by SAGE Publications Inc, dedicated to advancing the understanding and treatment of substance use disorders. With an established presence from 1995 to 2023, the journal boasts an impressive Q1 ranking in both Medicine (miscellaneous) and Psychiatry and Mental Health, positioning it among the top tier of academic publications in these fields. Researchers and professionals will find its articles, which are grounded in rigorous empirical studies and innovative interventions, essential for addressing the complex and multifaceted nature of substance abuse. Although not an open access publication, Substance Abuse maintains a commitment to sharing valuable insights and findings, making it a vital resource for those looking to enhance their knowledge and practice. Located in Thousand Oaks, CA, this journal serves as a critical forum for international dialogue and research dissemination, ensuring that current trends and challenges in substance use are thoughtfully examined and discussed within the academic community.